Kefir-derived probiotic mixture for children with autism spectrum disorder: a double-blind randomized clinical trial

Sarha A L de Queiroz1, Deivis O Guimarães2,3, Lara A Ferreira4

  • 1Translational Physiology and Pharmacology Laboratory, Graduate Program in Pharmaceutical Sciences, Vila Velha University, Avenida Comissário José Dantas de Melo, 21 - Boa Vista II, Vila Velha, Espírito Santos, 29102-920, Brazil. sarha.andrade@hotmail.com.

BMC Pediatrics
|January 17, 2026
PubMed
Abstract

No abstract available in PubMed .

Related Concept Videos

Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...